Avecho Biotechnology Investor Briefing – 8 December
Avecho Biotechnology (ASX: AVE) is a a pharma innovator offering a world-first drug delivery platform used in the projected US$55 billion cannabidiol market.
By clicking submit, I agree to the terms of the Reach Markets Financial Services Guide that includes the Privacy Statement.